Clinical Trial Update: The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Actos (pioglitazone) effects on glucose transporters in muscle in type 2 diabetes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: East Tennessee State University | Conditions: Diabetes Type 2 | Phase 4 | Status: COMPLETED